Abstract
This update summarises the in vitro and experimental in vivo activities of RP 59500 (quinupristin/dalfopristin) reported at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (1995) and the 3rd International Conference on the Macrolides, Azalides and Streptogramins (1996).